IOSP
Innospec Inc.
NASDAQ · Basic Materials · Chemicals - Specialty · US
$93.95
+0.89%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.8B | 1.8B | 1.8B | 1.9B | 2.0B |
| Cost of Revenue | 1.3B | 1.3B | 1.3B | 1.4B | 1.4B |
| Gross Profit | 505.9M | 492.4M | 542.9M | 591.1M | 586.7M |
| Operating Expenses | |||||
| R&D Expense | 52.1M | 51.0M | 47.8M | 41.7M | 38.7M |
| SG&A Expense | 304.0M | 285.1M | 314.0M | 387.8M | 360.7M |
| General & Admin Expense | 84.3M | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 100.0K | — | 3.2M | — | — |
| Total Operating Expenses | 356.2M | 336.1M | 365.0M | 429.5M | 399.4M |
| Cost and Expenses | 1.7B | 1.6B | 1.7B | 1.8B | 1.8B |
| Operating Income (EBIT) | 149.7M | 156.3M | 177.9M | 161.6M | 187.3M |
| Non-Operating | |||||
| Interest Income | 4.9M | 9.2M | — | — | — |
| Interest Expense | — | — | — | — | 1.1M |
| Net Interest Income | 4.9M | 9.2M | — | — | (1.1M) |
| Other Non-Op Income/Expense | (6.4M) | (18.2M) | (136.7M) | 12.8M | (2.7M) |
| Non-Operating Income (excl Interest) | 10.2M | 18.2M | (3.2M) | (12.8M) | 1.6M |
| EBT (Pre-Tax Income) | 143.3M | 138.1M | 41.2M | 174.4M | 184.6M |
| Income Tax Expense | 21.0M | 21.5M | 5.6M | 35.3M | 51.6M |
| Bottom Line | |||||
| Net Income | 121.5M | 116.6M | 35.6M | 139.1M | 133.0M |
| Earnings from Cont. Ops | 122.3M | 116.6M | 35.6M | 139.1M | 133.0M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 121.5M | 116.6M | 35.6M | 139.1M | 133.0M |
| Per Share | |||||
| Basic EPS | $4.91 | $4.69 | $1.43 | $5.60 | $5.37 |
| Diluted EPS | $4.90 | $4.67 | $1.42 | $5.56 | $5.32 |
| Revenue Per Share | $74.75 | $71.46 | $74.02 | $78.42 | $79.22 |
| Shares | |||||
| Basic Shares Outstanding | 24.6M | 24.9M | 24.9M | 24.9M | 24.8M |
| Diluted Shares Outstanding | 24.7M | 25.0M | 25.1M | 25.0M | 25.0M |
| Profitability Metrics | |||||
| EBITDA | 171.5M | 187.4M | 224.6M | 213.7M | 225.8M |
| D&A | 32.0M | 49.3M | 43.5M | 39.3M | 40.1M |
| EBIT | 139.5M | 138.1M | 181.1M | 174.4M | 185.7M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026